OM vs. ELMD, FONR, VANI, SMLR, HYPR, PXDT, ECOR, POCI, EDAP, and AXGN
Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Semler Scientific (SMLR), Hyperfine (HYPR), Pixie Dust Technologies (PXDT), electroCore (ECOR), Precision Optics (POCI), Edap Tms (EDAP), and AxoGen (AXGN). These companies are all part of the "electromedical equipment" industry.
Electromed (NYSE:ELMD) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, community ranking, media sentiment and dividends.
Electromed has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.
Outset Medical has a consensus target price of $5.42, indicating a potential upside of 127.59%. Given Electromed's higher possible upside, analysts plainly believe Outset Medical is more favorable than Electromed.
40.8% of Electromed shares are owned by institutional investors. 12.7% of Electromed shares are owned by company insiders. Comparatively, 3.5% of Outset Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Electromed has a net margin of 7.62% compared to Electromed's net margin of -132.54%. Outset Medical's return on equity of 10.32% beat Electromed's return on equity.
Electromed has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500. Comparatively, Outset Medical has a beta of 1.99, suggesting that its share price is 99% more volatile than the S&P 500.
In the previous week, Electromed and Electromed both had 2 articles in the media. Electromed's average media sentiment score of 0.33 beat Outset Medical's score of 0.06 indicating that Outset Medical is being referred to more favorably in the news media.
Outset Medical received 11 more outperform votes than Electromed when rated by MarketBeat users. However, 84.62% of users gave Electromed an outperform vote while only 37.93% of users gave Outset Medical an outperform vote.
Summary
Electromed beats Outset Medical on 10 of the 16 factors compared between the two stocks.
Get Outset Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Outset Medical Competitors List
Related Companies and Tools
